ID

15710

Descrizione

A Phase III Study of MPDL3280A (Anti-PD-L1) in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-paclitaxel Compared With Carboplatin + Nab-paclitaxel in Patients With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower 131]; ODM derived from: https://clinicaltrials.gov/show/NCT02367794

collegamento

https://clinicaltrials.gov/show/NCT02367794

Keywords

versioni (1)
  1. 09/06/16 09/06/16 -
Caricato su

9 giugno 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Non-Small Cell Lung Cancer NCT02367794

Inglese

Eligibility Non-Small Cell Lung Cancer NCT02367794

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
18 years or older
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
eastern cooperative oncology group (ecog) performance status 0 or 1
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
histologically or cytologically confirmed, treatment-naïve stage iv squamous nsclc
Descrizione

Therapy naive Lung squamous cell carcinoma stage IV

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0919936
UMLS CUI [1,2]
C0854994
previously obtained archival tumor tissue or tissue obtained from biopsy at screening
Descrizione

Tumor tissue sample Biopsy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0475358
UMLS CUI [1,2]
C0005558
measurable disease as defined by recist v1.1
Descrizione

Measurable Disease

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1513041
adequate hematologic and end organ function
Descrizione

Hematologic function | organ function

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0678852
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
active or untreated central nervous system (cns) metastasis
Descrizione

CNS metastases untreated

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0686377
UMLS CUI [1,2]
C0332155
malignancies other than nsclc within 5 years prior to randomization, with the exception of those with a negligible risk of metastasis or death treated with expected curative outcome
Descrizione

Malignant Neoplasms | Non-Small Cell Lung Carcinoma | At risk Neoplasm Metastasis | At risk Cessation of life

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0007131
UMLS CUI [3,1]
C1444641
UMLS CUI [3,2]
C0027627
UMLS CUI [4,1]
C1444641
UMLS CUI [4,2]
C0011065
pregnant or lactating women
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of autoimmune disease
Descrizione

Autoimmune Diseases

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0004364
history of idiopathic pulmonary fibrosis, organizing pneumonia, drug-induced pneumonitis, idiopathic pneumonitis, or evidence of active pneumonitis on screening chest computed tomography (ct) scan, history of radiation pneumonitis in the radiation field (fibrosis) is permitted
Descrizione

Idiopathic Pulmonary Fibrosis | Organized pneumonia | Drug-induced pneumonitis | Pneumonitis idiopathic | Pneumonitis Chest CT | Radiation Pneumonitis | Radiation Field | Fibrosis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1800706
UMLS CUI [2]
C0264383
UMLS CUI [3]
C1960026
UMLS CUI [4,1]
C3714636
UMLS CUI [4,2]
C0332240
UMLS CUI [5,1]
C3714636
UMLS CUI [5,2]
C0202823
UMLS CUI [6]
C0206063
UMLS CUI [7]
C1882536
UMLS CUI [8]
C0016059
positive test for human immunodeficiency virus (hiv)
Descrizione

HIV Seropositivity

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019699
active hepatitis b or hepatitis c
Descrizione

Hepatitis B | Hepatitis C

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
prior treatment with cd137 agonists or immune checkpoint blockade therapies, anti pd-1, and anti-pd-l1 therapeutic antibody
Descrizione

CD137 agonists

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0214721
UMLS CUI [1,2]
C0243192
severe infection within 4 weeks prior to randomization
Descrizione

Communicable Diseases Severe

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205082
significant history of cardiovascular disease
Descrizione

Cardiovascular Diseases

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0007222
Ritorna all'inizio della pagina

Similar models

Eligibility Non-Small Cell Lung Cancer NCT02367794

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
18 years or older
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0 or 1
boolean
C1520224 (UMLS CUI [1])
Therapy naive Lung squamous cell carcinoma stage IV
Item
histologically or cytologically confirmed, treatment-naïve stage iv squamous nsclc
boolean
C0919936 (UMLS CUI [1,1])
C0854994 (UMLS CUI [1,2])
Tumor tissue sample Biopsy
Item
previously obtained archival tumor tissue or tissue obtained from biopsy at screening
boolean
C0475358 (UMLS CUI [1,1])
C0005558 (UMLS CUI [1,2])
Measurable Disease
Item
measurable disease as defined by recist v1.1
boolean
C1513041 (UMLS CUI [1])
Hematologic function | organ function
Item
adequate hematologic and end organ function
boolean
C0221130 (UMLS CUI [1])
C0678852 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
CNS metastases untreated
Item
active or untreated central nervous system (cns) metastasis
boolean
C0686377 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Malignant Neoplasms | Non-Small Cell Lung Carcinoma | At risk Neoplasm Metastasis | At risk Cessation of life
Item
malignancies other than nsclc within 5 years prior to randomization, with the exception of those with a negligible risk of metastasis or death treated with expected curative outcome
boolean
C0006826 (UMLS CUI [1])
C0007131 (UMLS CUI [2])
C1444641 (UMLS CUI [3,1])
C0027627 (UMLS CUI [3,2])
C1444641 (UMLS CUI [4,1])
C0011065 (UMLS CUI [4,2])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Autoimmune Diseases
Item
history of autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Idiopathic Pulmonary Fibrosis | Organized pneumonia | Drug-induced pneumonitis | Pneumonitis idiopathic | Pneumonitis Chest CT | Radiation Pneumonitis | Radiation Field | Fibrosis
Item
history of idiopathic pulmonary fibrosis, organizing pneumonia, drug-induced pneumonitis, idiopathic pneumonitis, or evidence of active pneumonitis on screening chest computed tomography (ct) scan, history of radiation pneumonitis in the radiation field (fibrosis) is permitted
boolean
C1800706 (UMLS CUI [1])
C0264383 (UMLS CUI [2])
C1960026 (UMLS CUI [3])
C3714636 (UMLS CUI [4,1])
C0332240 (UMLS CUI [4,2])
C3714636 (UMLS CUI [5,1])
C0202823 (UMLS CUI [5,2])
C0206063 (UMLS CUI [6])
C1882536 (UMLS CUI [7])
C0016059 (UMLS CUI [8])
HIV Seropositivity
Item
positive test for human immunodeficiency virus (hiv)
boolean
C0019699 (UMLS CUI [1])
Hepatitis B | Hepatitis C
Item
active hepatitis b or hepatitis c
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
CD137 agonists
Item
prior treatment with cd137 agonists or immune checkpoint blockade therapies, anti pd-1, and anti-pd-l1 therapeutic antibody
boolean
C0214721 (UMLS CUI [1,1])
C0243192 (UMLS CUI [1,2])
Communicable Diseases Severe
Item
severe infection within 4 weeks prior to randomization
boolean
C0009450 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
Cardiovascular Diseases
Item
significant history of cardiovascular disease
boolean
C0007222 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial